|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: hematoma.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.If certain information is unknown, not available or does not apply, the section/field of the form is left blank.Manufacturer¿s reference number: (b)(4).
|
|
It was reported that a 35-year-old caucasian female patient underwent a primary breast augmentation with two 635cc mentor memorygel boost breast implants and experienced bilateral device migration, bilateral implant site hematoma, and capsular contracture (baker grade unknown) on the left side post-operatively.The patient mentioned that the right device was sitting lower and did not feel the same.The patient expressed concern and reported that the breast protheses were falling towards the armpits.The left side had scar tissue build up.As a result, the patient underwent a surgical intervention on (b)(6) 2025, for hematoma evacuations.At the time of this report, mentor has received no information regarding explantation or an expected explantation date.This report is for the left side device.
|